Nichole M. Neugebauer

Affiliations: 
Yale University, New Haven, CT 
Area:
Behavioral Pharmacology, Drug Abuse
Google:
"Nichole Neugebauer"
Mean distance: 14.07 (cluster 6)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mascia P, Neugebauer NM, Brown J, et al. (2018) Exposure to conditions of uncertainty promotes the pursuit of amphetamine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Neugebauer NM, Miyauchi M, Sato T, et al. (2017) Hippocampal GABAA antagonism reverses the novel object recognition deficit in sub-chronic phencyclidine-treated rats. Behavioural Brain Research
Miyauchi M, Neugebauer NM, Sato T, et al. (2017) Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats. Journal of Psychopharmacology (Oxford, England). 269881117731278
Rodríguez G, Neugebauer NM, Yao KL, et al. (2017) Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice. Pharmacology, Biochemistry, and Behavior
Miyauchi M, Neugebauer NM, Meltzer HY. (2017) Dopamine D4 receptor stimulation contributes to novel object recognition: Relevance to cognitive impairment in schizophrenia. Journal of Psychopharmacology (Oxford, England). 31: 442-452
Miyauchi M, Neugebauer NM, Oyamada Y, et al. (2015) Nicotinic receptors and lurasidone-mediated reversal of phencyclidine-induced deficit in novel object recognition. Behavioural Brain Research
Horiguchi M, Miyauchi M, Neugebauer NM, et al. (2015) Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism. Behavioural Brain Research
Singer BF, Neugebauer NM, Forneris J, et al. (2014) Locomotor conditioning by amphetamine requires cyclin-dependent kinase 5 signaling in the nucleus accumbens. Neuropharmacology. 85: 243-52
Neugebauer NM, Cortright JJ, Sampedro GR, et al. (2014) Exposure to nicotine enhances its subsequent self-administration: contribution of nicotine-associated contextual stimuli. Behavioural Brain Research. 260: 155-61
Meyer AC, Neugebauer NM, Zheng G, et al. (2013) Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo. Journal of Neurochemistry. 127: 187-98
See more...